Orchestra BioMed Holdings, Inc.
OBIO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $102,892 | $163,648 | $152,257 |
| - Cash | $42,012 | $18,749 | $18,348 | $22,261 |
| + Debt | $1,135 | $1,970 | $16,444 | $16,529 |
| Enterprise Value | – | $86,113 | $161,744 | $146,525 |
| Revenue | $861 | $836 | $868 | $253 |
| % Growth | 3% | -3.7% | 243.1% | – |
| Gross Profit | $812 | $790 | $824 | $195 |
| % Margin | 94.3% | 94.5% | 94.9% | 77.1% |
| EBITDA | -$20,232 | -$19,246 | -$18,672 | -$16,593 |
| % Margin | -2,349.8% | -2,302.2% | -2,151.2% | -6,558.5% |
| Net Income | -$20,828 | -$19,363 | -$18,755 | -$16,155 |
| % Margin | -2,419% | -2,316.1% | -2,160.7% | -6,385.4% |
| EPS Diluted | -0.4 | -0.5 | -0.49 | -0.42 |
| % Growth | 20% | -2% | -16.7% | – |
| Operating Cash Flow | -$14,550 | -$15,527 | -$16,616 | -$13,538 |
| Capital Expenditures | -$310 | -$34 | -$112 | -$106 |
| Free Cash Flow | -$14,860 | -$15,561 | -$16,728 | -$13,644 |